Christopher Paige, Director at AVROBIO, Inc. (AVRO), sold 15,000 shares at $28.00 ($420K) on 2020-02-11, disclosed to the SEC on 2020-02-11.
Scheduled sale ($420k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |